Emerging Strategies for Immunotherapy of Solid Tumors Using Lipid-Based Nanoparticles
Description
The application of lipid-based nanoparticles for COVID-19 vaccines and transthyretin-mediated amyloidosis treatment have highlighted their potential for translation to cancer therapy. However, their use in delivering drugs to solid tumors is limited